首页> 外国专利> Application of diindolylmethane and its precursors and their derivatives in the manufacture of drugs for the treatment of liver diseases

Application of diindolylmethane and its precursors and their derivatives in the manufacture of drugs for the treatment of liver diseases

机译:二吲哚基甲烷及其前体及其衍生物在制备治疗肝病药物中的应用

摘要

This invention relates to biopharmaceutical technology, specifically to the application of 3,3'-Diindolylmethane, indole-3-carbinol, and derivatives thereof in the preparation of drugs for treating such hepatic diseases as viral hepatitis, alcoholic hepatitis, drug-induced hepatitis, fatty liver, hepatic fibrosis and hepatic cirrhosis. The said indole-3-carbinol, diindolylmethane and derivatives thereof can effectively protect the human body from the damage resulting from ROS by inhibiting ROS-induced activation of hepatic stellate cells and correlated expression of collagen, which consequently ameliorates degree of hepatic fibrosis. Therefore they can be used in treatment of diseases related to hepatic fibrosis. As is verified in the animal models of hepatic fibrosis, the said indole-3-carbinol, diindolylmethane and derivatives thereof present excellent therapeutic effect and positive application prospect.
机译:本发明涉及生物制药技术,尤其涉及3,3'-二吲哚基甲烷,吲哚-3-甲醇及其衍生物在制备治疗病毒性肝炎,酒精性肝炎,药物性肝炎等肝病的药物中的应用。脂肪肝,肝纤维化和肝硬化。所述的吲哚-3-甲醇,二吲哚基甲烷及其衍生物可通过抑制ROS诱导的肝星状细胞的活化和胶原蛋白的相关表达,从而有效地保护人体免受ROS的损害,从而改善了肝纤维化的程度。因此,它们可以用于治疗与肝纤维化有关的疾病。如在肝纤维化动物模型中所证实的,所述吲哚-3-甲醇,二吲哚基甲烷及其衍生物具有优异的治疗效果,具有广阔的应用前景。

著录项

  • 公开/公告号JP5759000B2

    专利类型

  • 公开/公告日2015-08-05

    原文格式PDF

  • 申请/专利权人 南京大学;

    申请/专利号JP20130524335

  • 申请日2010-12-28

  • 分类号A61K31/404;A61P1/16;A61K47/44;A61K47/20;A61K47/40;A61K47/42;A61K9/48;C07D209/04;

  • 国家 JP

  • 入库时间 2022-08-21 15:29:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号